Bioavailability of bismuth from205Bi-labelled pharmaceutical oral Bi-preparations in rats
- 1 October 1991
- journal article
- Published by Springer Nature in Archives of Toxicology
- Vol. 65 (8) , 646-650
- https://doi.org/10.1007/bf02098030
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 205Bi/206Bi cyclotron production from Pb-isotopes for absorption studies in humansApplied Radiation and Isotopes, 1993
- Pharmakokinetik von Wismut-Präparaten bei Patienten mit Gastritis und UlkuskrankheitJournal of Molecular Medicine, 1990
- Bismuth Subsalicylate: History, Chemistry, and SafetyClinical Infectious Diseases, 1990
- Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthateEuropean Journal of Clinical Pharmacology, 1989
- Tissue and Subcellular Distribution of Bismuth Radiotracer in the Rat: Considerations of Cytotoxicity and Microdosimetry for Bismuth RadiopharmaceuticalsRadiation Research, 1987
- Pyloric Campylobacter infection and gastroduodenal diseaseThe Medical Journal of Australia, 1985
- Cinétique et distribution du 206Bi chez le rat et le lapin: un modèleThe International Journal of Applied Radiation and Isotopes, 1983
- TISSUE DISTRIBUTION OF ORALLY ADMINISTERED BISMUTH IN THE RATClinical and Experimental Pharmacology and Physiology, 1980
- [Bismuth treatment and blood bismuth levels].1977
- Performance parameters of the Hamburg 4 pi whole body radioactivity detectorPhysics in Medicine & Biology, 1977